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Extramedullary plasmacytoma (EMP) is an uncommon 
manifestation of plasma cell neplasia, which occurs 
outside the bone marrow. Intestinal involvement usu-
ally occur secondarily in multiple myeloma but it occur 
primarily less commonly. We experienced a woman 
who had a primary EMP localized in the stomach and 
the EMP was removed successfully by endoscopic 
submucosal dissection. The lesion was pathologically 
confirmed as confined to the gastric mucosa. (Gut 
and Liver 2009;3:334-337)
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INTRODUCTION
  Extramedullary plasmacytoma (EMP) is uncommon and 
represents about 3% of all plasma cell neoplasms. Almost 
90% of EMP occurs in the head and neck area in the up-
per respiratory tract; the gastrointestinal tract is a very 
rare site of involvement of this neoplasm.
1-3 Because EMP 
is highly sensitive to radiotherapy, surgery of head and 
neck disease is not routinely recommended. However, 
when it occurs as a non-upper respiratory disease, surgery 
is not inferior to radiotherapy.
3,4 Endoscopic submucosal 
dissection (ESD) is one type of endoscopic resection; it is 
a minimally invasive treatment modality for early-stage 
gastrointestinal neoplasms and is currently accepted in 
many countries as standard treatment for early gastric 
carcinoma (EGC) confined to the mucosa.
5,6 ESD is less 
invasive and more economical than surgery, and allows 
complete histopathological staging.
5,7,8 Here we present 
the first case of a gastric solitary EMP limited to the mu-
cosa treated by ESD.
CASE REPORT
  A 50-year-old woman was admitted to our hospital be-
cause of abnormal findings on an esophagogastroduodeno-
scopy performed for routine medical evaluation. The en-
doscopy showed well-demarcated, flat, yellow-whitish mu-
cosal changes on the anterior and posterior walls of the 
lower body of the stomach about 3 cm and 1 cm in diam-
eter, respectively (Fig. 1). The microscopic findings of the 
endocopic biopsies revealed extensive infiltration of plas-
ma cells with intranuclear immunoglobulin inclusion that 
were consistent with the diagnosis of plasmacytoma (Fig. 
2). The complete blood count and routine biochemistry 
were normal. After admission, bone marrow aspira-
tion/biopsy and peripheral blood smear were performed 
and there was no evidence of clonal marrow or peripheral 
plasmacytosis. Skull X-rays, abdomen and pelvic com-
puted tomography (CT) scans showed no underlying bone 
lesions or lymph node enlargement. Serum and urine im-
munoelectrophoresis demonstrated normal density of al-
bumin, the α2 fraction and β fraction, and the serum 
and urine immunofixation showed no specific monoclonal 
bands. The patient underwent endoscopic ultrasonography 
(EUS) to evaluate the depth of the plasmacytoma. There 
was abnormal mucosal thickening but no evidence of tu-
mor invasion into the submucosa (Fig. 3). Therefore, we 
diagnosed the patient with a solitary EMP of the stomach 
and an ESD was performed (Fig. 4).
  En bloc resection was carried out without complications 
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Fig. 1. Esophagogastroduodeno-
scopy. Well-demarcated, flat, yel-
low-whitish mucosal changes on 
the anterior and posterior walls 
of the lower body of the sto-
mach.
Fig. 2. (A) The constituent tumor cells consist of mature plasma cells together with plasmablast, which have large, central, 
prominent nucleoli. (B) Immunohistochemistry showing positivity for lamda chains confirming monoclonal nature of tumor. 
Fig. 3. Endoscopic ultrasonography finding showed extramu-
dullary plasmacytoma of stomach confined to the mucosa.
showed plasma cell infiltration and abundant intranuclear 
immunoglobulin inclusion with positive immunohistoche-
mistry for lamda chains that was limited to the mucosa 
with clear vertical margins (Fig. 5). Three months after 
the ESD, a follow up endoscopy was performed. Changes 
associated with scaring were present at the ESD site. 
Multiple biopsies of the ESD scar sites and surrounding 
tissue were performed. The microscopy showed normal 
gastric mucosa and no plasma cell infiltration of the scars 
and the surrounding tissue. Endoscopic biopsy, abdomen 
and pelvic CT, routine laboratory findings, and the pe-
ripheral blood smear 6 and 12 months after treatment al-
so demonstrated no evidence of tumor recurrence or de-
velopment of systemic myeloma.   
DISCUSSION
  Solitary EMP is less common than solitary plasmacyto-
ma of the bone (SBP), and accounts for approximately 336   Gut and Liver, Vol. 3, No. 4, December 2009
Fig. 4. Endoscopic submucosal 
dissection was performed with 
no significant complication.
3% of all plasma cell neoplasms.
1,2 Almost 90% of cases 
with EMP develop in the head and neck area, especially 
in the upper respiratory tract including the sinuses, nasal 
cavity, nasopharynx, and tonsils. The gastrointestinal tract 
is a very rare site for involvement of this neoplasm.
1-3 
The diagnosis of EMP is based on morphology and im-
munohistochemical demonstration of monoclonal κ or λ 
light chains or heavy chains found in localized plasma cell 
tumors in the absence of plasma cell proliferation else-
where, especially in the bone marrow, and must be dis-
tinguished from reactive plasmacytomas, plasma cell gran-
ulomas and lymphomas.
2-4 After curative treatment, about 
70% of patients with solitary EMP remain disease-free at 
10 years, and fewer than 30% of patients with EMP de-
velop systemic progression.
1-4
  Currently, there are no general guidelines for the treat-
ment of patients with EMP. However, EMP is highly sen-
sitive to radiotherapy, and surgery is not recommended 
for the initial treatment of head and neck disease because 
of its invasiveness.
3,4 However, for disease at other sites, 
including the gastrointestinal tract, surgery reveals no sig-
nificant difference in survival outcomes compared to 
radiotherapy.
3 There have been some cases reported with 
a solitary gastrointestinal plasmacytoma that was treated 
by surgery, bortezomib and dexamethasone, laparoscopic 
surgery, or Helicobactor pylori eradication.
9-11 However cur-
rently, endoscopic mucosal resection has been accepted as 
a reliable treatment for EGC limited to mucosa. ESD, a 
new method of endoscopic resection, was developed in 
order to increase en bloc resection rate, for larger lesions. 
But there still exists a limitation of ESD for infiltrative 
disease. This is because the safety margin is just a few 
millimeters in most cases. In our case the lesion was rela-
tively well demarcated to perform ESD. We performed 
ESD to treat solitary gastric EMP confined to the mucosa 
that was documented by EUS; this is the first case 
reported. We observed no significant side effects asso-
ciated with the ESD and no documented relapse over 12 
months after treatment. ESD has the advantages of being 
less invasive, less expensive, and has a lower incidence of 
side effects compared with conventional surgery or 
radiotherapy.
5,6,12
  Further study is needed to evaluate the outcomes of 
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Fig. 5. (A) Low-magnification view of an endoscopic sub-
mucosal dissection specimen indicating the presence of abun-
dant plasm a cells confined to m ucosa (H & E stain, × 100). (B)
High-magnification view of an endoscopic submucosal 
dissection specimen indicating intranuclear immunoglobulin
inclusion (H&E stain, ×400). (C) Immunohistochemistry sho-
wing positivity for lamda chains confirming monoclonal nature
of tumor.
suggest that ESD is safe, well-tolerated and an effective 
alternative treatment for solitary gastric EMP confined to 
the mucosa.
REFERENCES
1. Dimopoulos MA, Kiamouris C, Moulopoulos LA. Solitary 
plasmacytoma of bone and extramedullary plasmacytoma. 
Hematol Oncol Clin North Am 1999;13:1249-1257.
2. Weber DM. Solitary bone and extramedullary plasma-
cytoma. Hematology Am Soc Hematol Educ Program 
2005:373-376.
3. Alexiou C, Kau RJ, Dietzfelbinger H, et al. Extramedullary 
plasmacytoma: tumor occurrence and therapeutic concepts. 
Cancer 1999;85:2305-2314.
4. Dimopoulos MA, Hamilos G. Solitary bone plasmacytoma 
and extramedullary plasmacytoma. Curr Treat Options 
Oncol 2002;3:255-259.
5 . R e m b a c k e n  B J ,  G o t o d a  T ,  F u j i i  T ,  A x o n  A T .  E n d o s c o p i c  
mucosal resection. Endoscopy 2001;33:709-718.
6. Gotoda T. Endoscopic resection of early gastric cancer. 
Gastric Cancer 2007;10:1-11.
7. Soetikno RM, Gotoda T, Nakanishi Y, Soehendra N. En-
doscopic mucosal resection. Gastrointest Endosc 2003;57: 
567-579.
8. Ludwig K, Klautke G, Bernhard J, Weiner R. Minimally in-
vasive and local treatment for mucosal early gastric cancer. 
Surg Endosc 2005;19:1362-1366.
9. Katodritou E, Kartsios C, Gastari V, et al. Successful treat-
ment of extramedullary gastric plasmacytoma with the 
combination of bortezomib and dexamethasone: first re-
ported case. Leuk Res 2008;32:339-341.
10. Chetty R, Bramdev A, Reddy AD. Primary extramedullary 
plasmacytoma of the esophagus. Ann Diagn Pathol 2003; 
7:174-179.
11. Papadaki HA, Skordilis P, Minadakis G, et al. Complete re-
gression of primary gastric plasmacytoma following Helico-
bacter pylori eradication. Ann Hematol 2003;82:589-592.
12. Coia LR, Myerson RJ, Tepper JE. Late effects of radiation 
therapy on the gastrointestinal tract. Int J Radiat Oncol 
Biol Phys 1995;31:1213-1236.